Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Complete Genomics, Soon to Be a BGI Subsidiary, Wins Partial Victory in Illumina Suit

publication date: Oct 19, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Complete Genomics, the California sequencing company, gained a partial victory in Illumina’s patent suit against the company. The judge rejected Claim 1 of the suit, ruling that prior art shows Illumina’s technology was not novel. In September, BGI, the giant sequencing company headquartered in Shenzhen, announced it would buy Complete Genomics for $127 million. More details....

Stock Symbols: (NSDQ: GNOM) (NSDQ: ILMN)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors